Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Amorphous cefditoren pivoxil composition and process for producing the same

A composition and amorphous technology, applied in the field of pharmaceutical compositions for oral administration, can solve the problems of unsatisfactory production efficiency, process management and long time, and achieve high therapeutic effectiveness, good dissolution and stability excellent effect

Inactive Publication Date: 2004-10-13
MEIJI SEIKA KAISHA LTD
View PDF13 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] However, this method requires process management and a long time due to many processes, so it is not satisfactory in terms of production efficiency.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amorphous cefditoren pivoxil composition and process for producing the same
  • Amorphous cefditoren pivoxil composition and process for producing the same
  • Amorphous cefditoren pivoxil composition and process for producing the same

Examples

Experimental program
Comparison scheme
Effect test

manufacture example

[0063] Amorphous cefditoren and pivoxil compositions 1 to 7 of the present invention were prepared as follows.

[0064] Amorphous Composition 1

[0065] With 0.3g crystalline cefditoren pivoxil (manufactured by Meiji Seika Co., Ltd.), 2.7g sodium caseinate (manufactured by New Zealand Dairy Board) (the weight ratio of cefditoren pivoxil / casein sodium is 10 / 90) was put into a pulverizing container made of alumina, and pulverized for 30 minutes using a vibrating rod mill (manufactured by CMT, model TI-200) to obtain an amorphous composition 1.

[0066] Amorphous Composition 2

[0067] Mix 0.3 g of crystalline cefditoren pivoxil (manufactured by Meiji Seika Co., Ltd.), 2.7 g of crystalline cellulose (manufactured by Asahi Kasei Co., Ltd.) (the weight ratio of cefditoren pivoxil / crystalline cellulose is 10 / 90) was placed in a pulverizing container made of alumina, and pulverized for 30 minutes using a vibrating rod mill (manufactured by CMT: TI-200) to obtain an amorphous c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A composition of an amorphous cefditoren pivoxil excellent in stability and releasability; and a process for producing the amorphous composition. The composition comprises cefditoren pivoxil and a pharmaceutically acceptable organic polymer, and is characterized by being obtained by pulverizing crystalline cefditoren pivoxil in the presence of a pharmaceutically acceptable organic polymer and making the cefditoren pivoxil amorphous.

Description

[Background of the invention] [0001] field of invention [0002] The present invention relates to an amorphous cefditoren pivoxil composition with excellent stability and improved dissolution properties, a pharmaceutical composition for oral administration containing the amorphous composition, and a method for preparing the composition. [0003] Background technique [0004] Cefditoren pivoxil (Cefditoren pivoxil) is, in order to endow the antibiotic cefditoren (that is, (+)-(6R,7R)-7-[(Z)-2-( 2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethylenyl]-8-oxo -5-thio-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, its alias is [6R-[3(Z), 6α, 7β(Z)]]-7 -[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2 .0] oct-2-ene-2-carboxylic acid) excellent oral absorbability, and make trimethyl acetoxymethyl and its 4-position carboxylic acid carry out the ester binding of the new prodrug o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/14A61K9/16A61K9/48A61K31/546A61P31/00A61P31/04
CPCA61K9/1617A61K9/4858A61K9/146A61K9/1652A61K9/4866A61K31/546A61K9/1623A61P31/00A61P31/04
Inventor 太田真人
Owner MEIJI SEIKA KAISHA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com